Fiche centre
IRCCS San Raffaele Roma
Rome — Italy
Essais liés3clinical trials
VilleRomelocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05773885
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| VRRS Tablet (Khymeia s.r.l., Noventa Padovana, Italy) | Parkinson | Non applicable | NCT05773885 | TEMPO — Telerehabilitation in People With Parkinson's Disease | COMPLETED |
| Rimegepant 75mg daily dosing | Migraine | Phase 4 | NCT05217927 | Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens | COMPLETED |
| Rimegepant | Migraine | Phase 3 | NCT06616194 | A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine | ACTIVE_NOT_RECRUITING |